Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia

ClinicalTrials.gov ID: NCT01164722

Public ClinicalTrials.gov record NCT01164722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 18, 2026, 11:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Clinical Trial of Infrared Coagulator (IRC) Ablation Versus Expectant Management of Intra-Anal High Grade Intraepithelial Neoplasia (HGAIN) in HIV-infected Adults

Study identification

NCT ID: NCT01164722
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: AIDS Malignancy Consortium; Network
Enrollment: 120 participants

Conditions and interventions

Conditions

Interventions

clinical observation Other
infrared photocoagulation therapy Device

Other · Device

Eligibility (public fields only)

Age range: 27 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 31, 2011
Primary completion: Jun 30, 2015
Completion: Jun 30, 2016
Last update posted: Aug 3, 2020

2011 – 2016

United States locations

U.S. sites: 7
U.S. states: 5
U.S. cities: 6

Facility	City	State	ZIP	Site status
UCLA Clinical AIDS Research and Education (CARE) Center	Los Angeles	California	90095-1793	—
UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco	California	94143	—
Boston University Cancer Research Center	Boston	Massachusetts	02118	—
Laser Surgery Care	New York	New York	10010	—
New York Weill Cornell Cancer Center at Cornell University	New York	New York	10021	—
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	—
Benaroya Research Institute at Virginia Mason Medical Center	Seattle	Washington	98101	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01164722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 3, 2020 · Synced May 18, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01164722 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →